A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis
Clinical trial NCT04525352 · TERMINATED
Trial details
- NCT number
- NCT04525352
- Sponsor
- Rocket Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2021-05-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.